PAD

Question 1

Presentation of PAD

Answer 1

Question 2

Signs of PAD

Answer 2

Question 3

Ankle-Brachial Index (ABI)

Answer 3

Question 4

Prognosis of PAD

Answer 4

Question 5

ABI and Mortality

Answer 5

Question 6

Comorbidities of those with PAD

Answer 6

Question 7

Reducing the CV Risk in PAD

Answer 7

Question 8

Treatment of Claudication

Answer 8

Cilostazol (Pletal) - PDE3 inhibitor, increases cAMP. Inhibits platelet aggregation and causes arterial vasodilation.

Question 9

Surgical Options for PAD

Answer 9

Question 10

Medical Management of the Surgical Patient

Answer 10

Question 11

Etiologies of Acute Arterial Occlusion

Answer 11

Question 12

General Management of Acute Arterial Occlusion

Answer 12

Question 13

Classification and Management of

Acute Arterial Occlusion

Answer 13

Question 14

Large Vessel Vasculitides

Answer 14

Question 15

Medium Vessel Vasculitides

Answer 15

Question 16

Small Vessel Vasculitides

Answer 16

Question 17

Non-Inflammatory Arteriopathies

Answer 17

Question 18

Atheroembolism

Answer 18

Question 19

Epidemiology of AAA

Answer 19

Question 20

Risk Factors for AAA

Answer 20

Question 21

Presentation of AAA

Answer 21

Question 22

Screening Ultrasound for AAA

Answer 22

Question 23

Medical Management of AAA

Answer 23

Question 24

Surveillance of AAA

Answer 24

Question 25

Indications for Repair

Answer 25

Question 26

“Achilles Heel” of EVAR

Answer 26